ABPI

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

News and analysis related to the Association of the British Pharmaceutical Industry (ABPI).

Post-Brexit medicines regulation must have international scope

Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk

Share

X

Post-Brexit medicines regulation must have international scope

https://pharmaphorum.com/market-access-2/post-brexit-medicines-regulation-must-have-international-scope/

Are we measuring what matters most on uptake to medicines in England?

In the second of a two-part series, Leela Barham argues that whilst international comparisons of uptake are useful,

Share

X

Are we measuring what matters most on uptake to medicines in England?

https://pharmaphorum.com/market-access-2/measuring-uptake-medicines-england/

Getting better at measuring international uptake of medicines?

In part one of a two-piece series, Leela Barham looks at whether we are getting better at measuring

Share

X

Getting better at measuring international uptake of medicines?

https://pharmaphorum.com/market-access-2/getting-better-at-measuring-international-uptake-of-medicines/

Industry welcomes boost to health research in UK budget

Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK

Share

X

Industry welcomes boost to health research in UK budget

https://pharmaphorum.com/news/industry-welcomes-boost-to-health-research-in-uk-budget/

UK’s clinical research recovering slower than Euro peers, says ABPI

The pandemic had a negative effect on clinical research across all countries, but the UK seems to be

Share

X

UK’s clinical research recovering slower than Euro peers, says ABPI

https://pharmaphorum.com/news/uks-clinical-research-recovering-slower-than-euro-peers-says-abpi/

Blueprints for UK pharma-NHS joint working

Joint working could hold at least part of the answer to getting the NHS back on its feet

Share

X

Blueprints for UK pharma-NHS joint working

https://pharmaphorum.com/patients/pharma-nhs-joint-working-case-studies/

Collaborate to simplify cancer trials and accelerate post-pandemic recovery

How could simplifying the administration of clinical trials help cancer diagnosis, care, and treatment levels to exceed pre-pandemic

Share

X

Collaborate to simplify cancer trials and accelerate post-pandemic recovery

https://pharmaphorum.com/views-and-analysis/collaborate-to-simplify-cancer-trials-and-accelerate-post-pandemic-recovery/

How to balance the patient voice atop the shifting plates of HTA

The tectonic plates of healthcare technology assessment (HTA) have shifted – but where does the patient voice fit

Share

X

How to balance the patient voice atop the shifting plates of HTA

https://pharmaphorum.com/views-and-analysis/how-to-balance-the-patient-voice-atop-the-shifting-plates-of-hta/

Dementia, cancer headline UK’s 10-year plan for life sciences sector

The UK’s long-awaited Life Sciences Vision strategy has been published, setting out the government’s stall as it tries

Share

X

Dementia, cancer headline UK’s 10-year plan for life sciences sector

https://pharmaphorum.com/news/dementia-cancer-headline-uks-10-year-plan-for-life-sciences-sector/